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Abstract
We characterized different cationic lipid-based gene delivery systems consisting of both liposomes and nonliposomal structures, in terms
of their in vitro transfection activity, resistance to the presence of serum, protective effect against nuclease degradation and stability under
different storage conditions. The effect of lipid/DNA charge ratio of the resulting complexes on these properties was also evaluated. Our
results indicate that the highest levels of transfection activity were observed for complexes prepared from nonliposomal structures composed
of FuGENE 6. However, their DNA protective effect was shown to be lower than that observed for cationic liposome formulations when
prepared at the optimal (+/ ) charge ratio. Our results suggest that lipoplexes are resistant to serum up to 30% when prepared at a 2:1 lipid/
DNA charge ratio. However, when they were prepared at higher (+/ ) charge ratios, they become sensitive to serum for even lower
concentrations (10%). Replacement of dioleoyl-phosphatidylethanolamine (DOPE) by cholesterol enhanced the resistance of the complexes
to the inhibitory effect of serum. This different biological activity in the presence of serum was attributed to different extents of binding of
serum proteins to the complexes, as evaluated by the immunoblotting assay. Studies on the stability under storage show that lipoplexes
maintain most of their biological activity when stored at  80 jC, following their fast freezing in liquid nitrogen.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introdution
The development observed in molecular biology,
genomics and medical genetics has promoted the emer-
gence of novel therapeutic approaches, such as gene ther-
apy, addressed to several diseases including metabolic
genetic diseases, viral infections and cancer [1,2]. Never-
theless, the successful application of these strategies is
strongly dependent on the ability to transfer therapeutic
genes into target cells. Therefore, research in somatic gene
therapy has been focused on the development of suitable
carriers that, while exhibiting adequate features for in vivo
use, would also mediate efficient intracellular delivery of
genetic material [3].
So far, the majority of clinical trials have been based on
the use of viral vectors. In fact, these vectors have certain
advantages, including high levels of transduction, or effi-
cient and stable integration of foreign DNA into host
genome. The usefulness of viral vectors is limited, however,
by host immune and inflammatory reactions (in the case of
adenovirus), difficulty of large-scale production, size limit
of the exogenous DNA (in the case of adeno-associated
virus), random integration into the host genome (in the case
of retroviruses), and the risks of inducing tumorigenic
mutations and generating active viral particles through
recombination [4,5]. The drawbacks associated with the
use of viral vectors, namely those related to safety problems,
have prompted investigators to develop alternative methods
for gene delivery, cationic lipid-based systems being the
most representative. Ideally, it would be desirable to pro-
duce carriers of small size, which ensure protection of DNA,
prevent nonspecific interactions with blood components,
exhibit specific targeting, achieve high levels of transgene
expression without causing cytotoxicity and that can be
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easily generated in large scale and stored [6–8]. Although
cationic liposomes fulfill some of these requirements, they
have a limited efficiency of delivery and gene expression as
compared to viral vectors, toxicity at higher concentrations
and inability to reach tissues beyond the vasculature unless
directly injected into the tissue [9–12]. In addition, the
positive charge harboured by cationic lipid-based systems
may promote their nonspecific binding to cells such as
erythrocytes, lymphocytes and endothelial cells, as well as
to extracellular matrix proteins [13,14]. On the other hand,
the interaction with serum proteins, such as lipoproteins or
immunoglobulins, may result in their coating, thus leading
to an increase in their clearance rate from blood circulation
[15–18]. Both processes will limit the ability of the com-
plexes to reach target tissues and cells. The colloidal
stability of cationic liposome/DNA complexes has also been
considered a critical aspect, specially when neutral net
charges or high concentrations are required. Although
various studies on the stabilization of lipoplexes have been
reported [19,20], the use of freshly prepared complexes is
still a requirement in therapeutic protocols.
In this work, we have characterized various lipid-based
gene delivery systems aiming at identifying critical param-
eters for their biological activity and stability. In particular,
we evaluated the physicochemical properties of these sys-
tems in terms of their size and zeta potential and attempts
were made to relate such properties to their ability to protect
DNA and to prevent their interaction with serum proteins. In
addition, lipid-based carriers exhibiting different features
were tested for their biological activity and stability.
2. Materials and methods
2.1. Preparation of cationic liposomes and their complexes
with DNA
Small unilamellar cationic liposomes (SUV) were pre-
pared from a 1:1 (mol ratio) mixture of 1,2-dioleoyl-3-
(trimethylammonium) propane (DOTAP) and dioleoyl-
phosphatidylethanolamine (DOPE) or cholesterol (Chol)
and from a 2:1:1 (mol ratio) mixture of DOTAP, DOPE
and Chol, by extrusion of multilamellar liposomes (MLV).
Briefly, lipids (Avanti Polar Lipids, Alabaster, AL) dis-
solved in CHCl3 were mixed at the desired molar ratio
and dried under vacuum in a rotatory evaporator. The dried
lipid films were hydrated with deionized water to a final
lipid concentration of 6 mM and the resulting MLV were
then sonicated, for 3 min, and extruded, 21 times, through
two stacked polycarbonate filters of 50 nm pore diameter
using a Liposofast device (Avestin, Toronto, Canada). The
resulting liposomes (SUV) were then diluted five times with
deionized water and filter-sterilized utilizing 0.22 Am pore-
diameter filters (Schleicher & Schuell). Complexes were
prepared by sequentially mixing 100 Al of a Hepes-buffered
saline solution (HBS) (100 mM NaCl, 20 mM HEPES, pH
7.4), with liposomes (volume was dependent on the (+/ )
charge ratio) and with 100 Al of HBS solution containing 1
Ag of pCMVluc (VR-1216; a gift of Dr. P. Felgner (Vical,
San Diego, CA)). The mixture was further incubated for 15
min at room temperature. Complexes prepared from the
commercially available formulations (DOTAP, FuGENE 6
and 1,3-dioleoyloxy-2-(6-carboxy-spermyl)-propylamid
(DOSPER) (Boehringer Mannheim, Mannheim, Germany))
were obtained in a similar manner to that described above.
2.2. Physicochemical characterization of complexes
Complexes were characterized with respect to their size
and zeta potential using a Coulter N4 Plus and a Coulter
DELSA 440 (Coulter Corporation, Miami, FL), respec-
tively. The Coulter N4 Plus is a PCS (photon correlation
spectroscopy)-based technique, which uses autocorrelation
spectroscopy of scattered laser light to determine its time-
dependent fluctuations resulting from the Brownian motion
of particles in suspension. The light intensity scattered at a
given angle is detected by a photo-multiplier whose output
current is passed to an autocorrelator, which analyses time
dependence, determining the rate of diffusion or Brownian
motion of the particles and hence their size. The detection
angle is fixed at 90j. The DELSA 440 is a laser-based
multiangle particle electrophoresis analyser that measures
the electrophoretic mobility and zeta potential distribution
simultaneously with the hydrodynamic size of particles in
suspension. Cationic liposome/DNA complexes were pre-
pared immediately before analysis. Samples of the prepared
complexes were placed in the measuring cell, whose posi-
tion was adjusted to cover a previously determined sta-
tionary layer, and an electric current of 3.0 mAwas applied.
Measurements were recorded and the zeta potential was
calculated for each scattering angle (8.6j, 17.1j, 25.6j and
34.2j). Data represent the meanF S.D. obtained for the
different angles of three measurements. All complexes
showed a unimodal distribution for zeta potential, while a
polymodal distribution was observed for size measurements.
2.3. Cells
COS-7 cells (American Type Culture Collection, Rock-
ville, MD) were maintained at 37 jC, under 5% CO2, in
Dulbecco’s modified Eagle’s medium-high glucose (DMEM-
HG) (Irvine Scientific, Santa Ana, CA) supplemented with
10% (v/v) heat-inactivated fetal bovine serum (FBS) (Sigma,
St. Louis, MO), penicillin (100 U/ml), streptomycin (100 Ag/
ml) and L-glutamine (4 mM). For transfection, 0.4 105
COS-7 cells were seeded in 1 ml of medium in 48-well
culture plates and used at 50–70% confluence.
2.4. Transfection activity
Cells were rinsed twice with serum-free medium and
then covered with 0.3 ml of DMEM-HG (without serum,
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unless indicated otherwise) before lipid/DNA complexes
were added. Lipid/DNA complexes were added gently to
cells in a volume of 0.2 ml per well. After 4-h incubation (in
5% CO2 at 37 jC), the medium was replaced with DMEM-
HG containing 10% FBS, and the cells were further incu-
bated for 48 h. The cells were then washed twice with
phosphate-buffered saline solution (PBS) and 100 Al of lysis
buffer (1 mM DTT; 1 mM EDTA; 25 mM Tris–phosphate
(pH = 7.8); 8 mM MgCl2; 15% glycerol; 1% (v/v) Triton X-
100) were added to each well. The level of gene expression
in the lysates was evaluated by measuring light production
by luciferase in a Mediators PhL luminometer (Mediators
Diagnostika, Vienna, Austria) and using a standard curve for
luciferase activity. The protein content of the lysates was
measured by the Dc Protein Assay reagent (Bio-Rad,
Hercules, CA) using bovine serum albumin as the standard.
The data were expressed as nanograms of luciferase per
milligram of total cell protein.
2.5. Interaction of cationic liposome/DNA complexes with
plasma proteins
The assay for determining the interaction of cationic
liposome/DNA complexes with plasma proteins is based
on the retention of the complexes by a 200 nm Anopore
membrane (Whatman, Kent, UK) and using the protocol
described by Ogris et al. [15]. Following their preparation,
the complexes were incubated with 2% of human plasma for
30 min at 37 jC. The membrane of microcentrifuge tube
filters (Whatman; 200 nm Anopore membrane) was satu-
rated with 500 Al bovine serum albumin (1 mg/ml) to reduce
unspecific interaction of plasma proteins with the membrane
and was washed three times with 500 Al of HBS solution.
The mixture of complexes and plasma was applied on to the
membrane, filtered by centrifugation at 10000 g and
washed three times with 500 Al HBS. The residue (com-
plex-bound plasma proteins) was eluted with 100 Al HBS
containing 5% (w/v) SDS. Samples (eluate) and control
(HBS solution treated in the same way) were diluted 10
times with HBS and two times with sample buffer (100 mM
Tris–HCl (pH = 6.8); 4% (w/v) SDS; 20% (v/v) glycerol;
0.2% (w/v) bromphenol blue), and the associated proteins
denaturated in boiling water for 3 min. Aliquots of the
treated samples and control were then applied on to a 7.5%
SDS polyacrylamide gel and separated at 180 V for 1 h in a
Mini-PROTEAN II electrophoresis cell (Bio-Rad). For
immunological identification of the proteins, a gel was
blotted on to a Hybond P (PVDF) membrane via semidry
blotting (Bio-Rad) at 15 V for 10 min. Unspecific binding
was blocked by incubating the blot with 5% milk powder in
TBST (2.5 mM Tris–HCl (pH = 7.6); 15 mM NaCl; 0.1%
Tween 20) for 2 h at room temperature (RT). The blots were
incubated for 1 h at RT with the antibody solutions (anti-
bodies were diluted in TBST) containing rabbit anti-human
complement C3 (Serotec, Oxford, England) 1:4000 or rabbit
anti-human albumin (Rockland, Gilbertsville, PA) 1:4000.
As second antibody, an alkaline phosphatase (AP) conjugate
with goat-anti-rabbit IgG (Amersham Pharmacia Biotech)
1:20000, was used. After 1-h incubation at RT, the blots
were washed several times with TBST and incubated with
ECF (alkaline phosphatase substrate) (20 Al of ECF/cm2 of
membrane) for 5 min at RT and then submitted to fluo-
rescence detection at 570 nm using a Storm-860 (Molecular
Dynamics, Sunnyvale, CA).
2.6. Ethidium bromide intercalation assay
The accessibility of ethidium bromide to the DNA asso-
ciated with the complexes was monitored at 37 jC, for 2 min,
in a SPEX Fluorolog 2 fluorometer (SPEX Industries,
Edison, NJ). The fluorescence was read at excitation and
emission wavelengths of 518 and 605 nm, respectively,
using 1 mm excitation and 2 mm emission slits. The sample
chamber was equipped with a magnetic stirring device, and
the temperature was controlled with a thermostatted circulat-
ing water bath. The fluorescence scale was calibrated such
that the initial fluorescence of EtBr (20 Al of a 2.5 mM
solution added to a cuvette containing 2 ml HBS solution)
was set at residual fluorescence. The value of fluorescence
obtained upon addition of 1 Ag DNA (control) was set as
100%. Cationic liposome/DNA complexes (1 Ag DNA) were
added to the cuvette containing 2 ml HBS solution followed
by addition of 20 Al of EtBr. The amount of DNA available
to interact with the probe was calculated by subtracting the
values of residual fluorescence from those obtained for the
samples and expressed as the percentage of the control.
2.7. Resistance to DNase I action
Resistance of cationic liposome/DNA complexes to
DNase I (Sigma) was determined by electrophoresis and
spectrofluorimetry. DNase I was maintained in a buffer
solution (50 mM Tris–HCl (pH = 7.5); 10 mM MnCl2; 50
Ag/ml BSA). Complexes were submitted to DNase I action
(5 units DNase I/Ag of DNA), during 30 min to 37 jC,
followed by inactivation of the enzyme upon incubation with
0.5 M EDTA (1 Al/unit of DNase I). Parallel experiments
were performed by incubating samples under the same
experimental conditions, except that DNase I was previously
inactivated. Electrophoresis was performed in 1% agarose
gel prepared in TBE solution (89 mM Tris-buffer (pH = 8.6);
89 mM boric acid; 2.5 mM EDTA) and containing 1 Ag/ml of
EtBr. Following incubation of the complexes with DNase I
(active or inactive), aliquots corresponding to 200 ng of
DNA, to which 5 Al of loading buffer (15% (v/v) ficoll 400;
0.05% (w/v) bromphenol blue; 1% (w/v) SDS; 0.1 M EDTA;
pH = 7.8) have been previously added, were placed in the
gel. The electrophoresis elapsed, for 1 h and 45 min,
applying a voltage of 100 V. In some experiments, lipid
extraction was performed following incubation of the com-
plexes with DNase I (active or inactive). Briefly, a phenol,
chloroform and alcohol isoamyl mixture (25:24:1) was
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added to the complexes in a volume ratio of 1:1 and
subsequently shaken and centrifuged at 10000 g for 10
s. 2-Propanol was added to the aqueous phase containing
DNA 1:2 (v/v) and the solution was shaken and maintained
at  20 jC, for 30 min, to facilitate DNA precipitation. After
centrifugation (14000 g, 15 min, 4 jC), the supernatant
was aspirated and the pellet washed again with 1 ml of 2-
propanol. Finally, the pellet was let to dry off, dissolved in
HBS, and analysed by electrophoresis.
For spectrofluorimetric measurements, following treat-
ment of the complexes with DNase I (active or inactive), the
same experimental procedure as described for the EtBr
access to the complexes was carried out. The extent of
DNA degradation was determined according to the follow-
ing equation:
DNAdegradationð%Þ ¼ ðFi  FaÞ=ðF100  F0Þ  100 ð1Þ
where Fi is the fluorescence value emitted by EtBr in the
presence of the complexes treated with the inactive enzyme,
Fa is the fluorescence value emitted by EtBr in the presence
of the complexes treated with the active enzyme, F100 is the
fluorescence value emitted by EtBr in the presence of 1 Ag
of DNA and F0 is the residual fluorescence of EtBr.
3. Results
3.1. Physicochemical characterization of the lipid-based
complexes
The successful application of gene therapy depends on
available carriers to efficiently deliver genetic material into
target cells. Such efficacy is strongly dependent on their
physicochemical properties [6,21].
Fig. 1 illustrates the values of the zeta potential and size
(mean diameter) of DOTAP:DOPE/DNA complexes pre-
pared at different lipid/DNA (+/ ) charge ratios. As can be
observed, increasing the amount of cationic liposomes with
respect to a fixed amount of DNA resulted in an increase of
the overall charge of the complexes as evaluated by zeta
potential measurements. Complexes prepared at 1/2, 1/1 and
4/1 (+/ ) charge ratios exhibited a mean diameter ranging
from 200 to 400 nm, while lipoplexes prepared at 2/1, which
were only slightly positive, exhibited large mean diameters
(between 1300 and 2000 nm).
Table 1 summarizes the values for zeta potential and
mean diameter obtained for the various complexes includ-
ing, those prepared from different cationic liposome for-
mulations and those prepared with the FuGENE 6
transfection reagent. As can be observed, the values for
the zeta potential and mean diameter of the complexes did
not differ significantly among the different cationic lip-
osome formulations. However, complexes prepared from
FuGENE 6 (3/1 (v/w)) presented an overall charge slightly
positive (close to those obtained for the liposome-based
complexes when prepared at a 2/1 (+/ ) charge ratio) and
a mean diameter double that obtained for the liposome-
based complexes prepared at the other charge ratios.
3.2. Biological activity of the complexes
The biological activity mediated by cationic liposome/
DNA complexes prepared from DOTAP:DOPE (1:1),
DOTAP:Chol (1:1) and DOTAP:DOPE:Chol (2:1:1)
depends on their (+/ ) charge ratio, those prepared at 2/1
(+/ ) charge ratio being the most active independently of
the liposome composition. Among the different formula-
tions tested, DOTAP:Chol/DNA complexes were those
exhibiting the highest levels of transfection (Fig. 2).
A comparison of the biological activity of the various
lipoplexes obtained from cationic liposomes prepared in our
laboratory and those using commercially available trans-
fection reagents (DOTAP, DOSPER and FuGENE 6) is
shown in Fig. 3. The levels of transfection mediated by
DOTAP/DNA complexes were of the same order of magni-
tude as those obtained for complexes prepared from cationic
liposomes produced in our laboratory, under the same
experimental conditions (compare to Fig. 2). On the other
hand, DOSPER/DNA complexes prepared at 8/1 (+/ )
charge ratio exhibited a biological activity approximately
five times higher than that observed for the best condition
presented in Fig. 2 (DOTAP:Chol/DNA at 2/1 charge ratio).
Nevertheless, the highest levels of transfection were
obtained for FuGENE 6/DNA complexes, these being
approximately 50 times higher than those obtained for
DOTAP:Chol/DNA at 2/1 charge ratio.
3.3. Effect of serum of transfection activity
Aiming at predicting the in vivo behaviour of the
complexes upon their intravenous administration, transfec-
tion studies were performed in the presence of different
Fig. 1. Dependence of zeta potential and mean diameter of DOTAP:DOPE/
DNA complexes on their lipid/DNA charge ratio. DOTAP:DOPE/DNA
complexes were prepared at the lipid/DNA charge ratios (+/ ) (1/2, 1/1,
2/1 and 4/1) as described in Materials and methods. Zeta potential
measurements of the different complexes were performed using a CoulterR
DELSA 440 Instrument. Data represent the meanF S.D. of at least three
independent experiments.
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amounts of serum. As shown in Fig. 4, the effect of serum on
transfection was dependent on the formulation and on the
charge ratio tested. DOTAP:DOPE/DNA (4/1), DOTAP:
Chol/DNA (4/1) and FuGENE 6/DNA were the complexes
where the most significant inhibition was observed, the
reduction with the respect to the control being approximately
90%, 95% and 60%, respectively. The transfection activity of
DOTAP:DOPE/DNA (2/1) was inhibited only by 25%, while
that of DOTAP:Chol/DNA (2/1) was not significantly
affected by the presence of serum. It should be noted that
the inhibitory effect of serum was essentially independent of
its final concentration in cell culture medium (10% and 30%).
Table 1
The zeta potential and mean diameter of lipid-based complexes
Complexes Zeta potential
(mV)
Mean diameter
(nm)
DOTAP:DOPE/DNA (1:2)  41.7 (F 3.1) 266.3 (F 15.37)
charge ratio (+/ ) (1:1)  30.2 (F 5.45) 344.7 (F 37.5)
(2:1) 12.7 (F 2.4) 1609 (F 333.8)
(4:1) 39.8 (F 4.3) 223.8 (F 23.9)
DOTAP:Chol/DNA (1:2)  35.6 (F 3.5) 220.7 (F 17.9)
charge ratio (+/ ) (1:1)  30.3 (F 2.5) 245 (F 15)
(2:1) 10.3 (F 3.1) 1864.5 (F 450.9)
(4:1) 38.9 (F 2.2) 272.5 (F 20.4)
DOTAP:DOPE:Chol/DNA (1:1)  30.2 (F 3.6) 267.5 (F 24.7)
charge ratio (+/ ) (2:1) 10.7 (F 4.1) 1676.7 (F 315.6)
FuGENE 6/DNA (v/w) (3:1) 11.3 (F 3.3) 578.7 (F 42.9)
DOTAP:DOPE (1:1), DOTAP:Chol (1:1) and DOTAP:DOPE:Chol (2:1:1)
liposomes were prepared in our laboratory as described in Materials and
methods. The results represent the meanF S.D. of at least three independent
experiments.
Fig. 2. Effect of lipoplex charge ratio (+/ ) on luciferase gene expression
in COS-7 cells. Cells were rinsed twice with serum-free medium and then
covered with 0.3 ml of DME-HG before cationic liposome/DNA complexes
were added. The liposomes (prepared in our laboratory) were complexed
with 1 Ag of pCMVluc at the indicated theoretical lipid/DNA charge ratios.
After incubation for 4 h, the medium was replaced with DME-HG
containing 10% FBS and the cells were further incubated for 48 h. The level
of gene expression was evaluated as described in Materials and methods.
The data are expressed as nanograms of luciferase per milligram of total cell
protein (meanF S.D. obtained from triplicates), and are representative of
three independent experiments.
Fig. 3. Effect of lipoplex charge ratio (+/ ) and volume/weight ratio on the
levels of transfection of COS-7 cells. Complexes were prepared from
commercially available cationic liposome formulations (DOTAP and
DOSPER) and from the transfection reagent (FuGENE 6). Experiments
were performed as described in the legend to Fig. 2. The data, expressed as
nanograms of luciferase per milligram of total cell protein, indicate the
meanF S.D. obtained from triplicates, and are representative of three
independent experiments.
Fig. 4. Effect of presence of serum on luciferase gene expression in COS-7
cells. Cells were covered with 0.3 ml of DME-HG enriched with FBS, in
order to obtain a final concentration of 10% or 30%, before lipid/DNA
complexes were added. After incubation for 4 h, the medium was replaced
with 1 ml of medium containing 10% FBS and the cells were further
incubated for 48 h. The level of gene expression was evaluated as described
in Materials and methods. The data are expressed as nanograms of
luciferase per milligram of total cell protein. The results correspond to the
meanF S.D. obtained from triplicates, and are representative of at least two
independent experiments.
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3.4. Interaction of the complexes with plasma proteins
As illustrated above, the presence of serum decreased the
transfection activity of the complexes, most likely through
the establishment of their interaction with serum proteins. In
an attempt to clarify this issue, the dependence of this
interaction on the composition and (+/ ) charge ratio of
the complexes was investigated by Western blotting. For
this purpose, antibodies against human albumin and C3
human complement protein were used. These proteins were
investigated because albumin is the most abundant protein
in serum and C3 is known to play a major role in
opsonization [22,23].
Fig. 5 shows the bands corresponding to albumin (A) and
C3 (B) bound to DOTAP:Chol/DNA and DOTAP:DOPE/
DNA complexes upon their incubation with 2% human
plasma. As shown, increasing the (+/ ) charge ratio of
the complexes prepared from both formulations tested
resulted in an increase in the extent of protein binding, the
highest levels being observed for the positively charged
complexes (4/1 (+/ ) charge ratio). Independently of the
lipid/DNA charge ratio, DOTAP:DOPE/DNA complexes
bound to albumin more extensively than DOTAP:Chol/
DNA complexes. A similar pattern was observed for bind-
ing of the complexes to C3 complement protein when the
complexes were prepared at 4/1 (+/ ) charge ratio, while
for 2/1 charge ratio, no significant differences for the extent
of binding were observed between DOTAP:Chol/DNA and
DOTAP:DOPE/DNA complexes.
3.5. Protection of DNA associated to the complexes
Aiming at evaluating the ability of the complexes to
condense and protect DNA, the complexes were tested in
terms of the access of EtBr to DNA and of resistance to
DNase degradation.
3.5.1. Access of ethidium bromide to DNA associated to the
complexes
Ethidium bromide is a monovalent DNA-intercalating
agent whose fluorescence is dramatically enhanced upon
binding to DNA and quenched when displayed by higher
affinity compounds or by condensation of the DNA struc-
ture. Therefore, this probe has been used to examine the
ability of cationic lipids to protect DNA [24]. Fig. 6 shows
that EtBr fluorescence decreased with increasing the (+/ )
charge ratio of the complexes, independently of the cationic
liposome formulation used in their preparation. These
results clearly indicate that an increase in the amount of
cationic liposomes led to a higher degree of DNA conden-
sation and protection as compared to that observed when
complexes are prepared at low lipid/DNA charge ratios.
DOTAP:Chol/DNA complexes prepared at either 2/1 or 4/1
charge ratio allowed a complete protection of DNA. Regard-
ing the FuGENE 6/DNA complexes (at a 3/1 v/w), the
access of EtBr to DNA indicates that a great amount of
DNA was still exposed (approximately 40% of the total
DNA), similar to what was observed for cationic liposome/
DNA complexes when prepared at a 1/1 (+/ ) charge ratio.
3.5.2. Resistance to DNase I action
In an attempt to demonstrate the degree of DNA protec-
tion mediated by cationic liposomes from attack by
nucleases in vivo, an in vitro DNase I protection assay
was performed.
Fig. 7 illustrates the electrophoretic resulted obtained
upon incubation of the complexes with active or inactive
DNase I. As shown, similar patterns can be observed for the
Fig. 5. Interaction of cationic liposome/DNA complexes with human
albumin (A) and C3 protein of the human complement (B). Control (HBS)
(1); DOTAP:Chol/DNA (+/ ) (4/1) (2); DOTAP:Chol/DNA (+/ ) (2/1)
(3); DOTAP:DOPE/DNA (+/ ) (4/1) (4); DOTAP:DOPE/DNA (+/ )
(2/1) (5); DOTAP:DOPE/DNA (+/ ) (1/1) (6). Complexes were incubated
at 37 jC, for 30 min, with human plasma and both albumin and C3 were
identified by immunoblotting as described in Materials and methods. Extent
of interaction (%), for each experimental condition, was calculated with
respect to the sum of the intensities of the bands for each one of the proteins
(considered as 100%).
Fig. 6. Accessibility of ethidium bromide to DNA associated with the
complexes. Complexes (DOTAP:DOPE/DNA, DOTAP:Chol/DNA and
FuGENE 6/DNA) containing 1 Ag DNA were incubated with EtBr as
described in Materials and methods. The amount of DNA available to
interact with the probe was calculated by subtracting the values of residual
fluorescence from those obtained for the samples and expressed as the
percentage of the control. Control corresponds to free DNA, but in the same
amount as that associated with the complexes (100% of EtBr accessibility).
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DNA degradation and for the access of EtBr (compare to Fig.
6). In fact, increasing the lipid/DNA (+/ ) charge ratio of
the complexes results in a decrease of DNA digestion, as
reflected by the difference between the intensity of the bands
corresponding to the complexes exposed to active and
inactive DNase I (lanes 2, 4, 6, 8, 10 and 3, 5, 7, 9,
respectively). DNA protection against DNase I was essen-
tially achieved for the complexes prepared at the 2/1 and 4/1
(+/ ) charge ratios. Surprisingly, no bands were observed
for the FuGENE 6/DNA complexes irrespective of whether
DNase I was active or inactive. Therefore, these results were
not in accordance with those obtained when the DNA
protection was evaluated in terms of access of EtBr, where
approximately 60% of protection was observed. These
intriguing results were most likely attributed to the chemical
nature of FuGENE 6 which, despite being unknown, may
interfere with the electrophoretic mobility of DNA. In order
to circumvent this difficulty, the lipid component of the
complexes was extracted before their incubation with DNase
I. As Fig. 8 illustrates, the bands corresponding to FuGENE
6/DNA complexes exposed to inactive DNase I are now
visible, exhibiting higher intensity than that observed upon
treatment with active DNase I (lanes 3 and 4, respectively).
Therefore, it can be concluded that FuGENE 6 was not able
to ensure an effective protection against DNase I, in contrast
to the cationic liposome-based complexes particularly at
high lipid/DNA (+/ ) charge ratio. It should be noted that
for the latter complexes, no significant differences, in term of
band intensities, were obtained upon extraction of the lipid
components (data not shown).
Despite lipid extraction, the results obtained for FuGENE
6 were still inconclusive since the agarose gel assay did not
have enough sensitivity to allow a quantitative evaluation of
DNA protection, as clearly suggested by the low intensity of
the bands as compared to the control (Fig. 8, lanes 3 and 1,
respectively). Therefore, the access of EtBr to the genetic
material following its degradation by DNase I was evaluated
by spectrofluorimetry. Assuming that a complete DNA
degradation corresponds to 0% EtBr fluorescence and that
intact DNA (obtained upon incubation with inactive DNase
I) corresponds to 100% fluorescence, it was possible to
quantitate the degree of DNA protection conferred by
FuGENE 6 (Section 2.7, Eq. (1)). Our results indicate that
approximately 36% of DNA degradation occurred for this
transfection reagent, while only 3% of degradation was
observed for the DOTAP:DOPE/DNA complexes prepared
at 2/1 (+/ ) charge ratio (data not shown).
3.6. Biological stability of the complexes upon storage
The development and production of carriers for in vivo
gene delivery should fulfill a number of requirements includ-
ing the ability to be stored, without losing their biological
stability. This issue is particularly relevant when repeated
administration is needed. Therefore, in this work, we inves-
tigated the effect of different storage conditions, namely
duration and temperature, on the maintenance of the trans-
fection activity of the DOTAP:Chol/DNA complexes pre-
pared at a 2/1 (+/ ) lipid/DNA charge ratio. For this
purpose, complexes prepared immediately before the trans-
fection experiments were used as controls. The results
presented in Fig. 9 indicate that the storage temperature
strongly affects the transfection activity. Complexes stored
for 1 day at both 25 and 4 jC lose about 70% of their activity,
this reduction being even more pronounced for longer
periods of incubation. Storage of the complexes at  20
jC resulted in a 50% decrease of their ability to transfect
COS-7 cells, independent of the duration of storage. Never-
theless, when fresh complexes were immediately frozen in
liquid nitrogen and stored at  80 jC, no significant effect
on their transfection activity was observed over the time
range between 1 and 20 days. The maintenance of the
biological activity of the complexes under these conditions
clearly suggests that no major changes in their physicochem-
ical properties occurred during the freezing, storage and
thawing processes. Zeta potential and size measurements
of the complexes upon their storage support this hypothesis,
since no significant differences were observed as compared
to freshly prepared complexes (data not shown).
Since our best results were obtained when the complexes
are stored at  80 jC, we investigated whether the other
Fig. 8. DNase I resistance of the complexes following lipid extraction.
Control + inactive DNase I (1); control + active DNase I (2); FuGENE/DNA
(v/w) (3/1) + inactive DNase I (3) and FuGENE/DNA (v/w) (3/1) + active
DNase I (4). Experiments were carried out as described in the legend to Fig.
7, except that before the electrophoresis, lipid extraction was performed.
Fig. 7. Resistance of cationic liposome/DNA complexes to DNase I.
Control (1 and 2); DOTAP:DOPE/DNA (+/ ) (1/2) (3 and 4);
DOTAP:DOPE/DNA (+/ ) (1/1) (5 and 6); DOTAP:DOPE/DNA (+/ )
(2/1) (7 and 8); DOTAP:DOPE/DNA (+/ ) (4/1) (9 and 10) and FuGENE/
DNA (v/w) (3/1) (11 and 12). Incubations with inactive DNase I (odd
numbers) or with active DNase I (even numbers) were performed at 37 jC,
for 30 min, using 10 units DNase I per microgram of DNA. Control
corresponds to the free DNA, but in the same amount as that associated
with the complexes. Electrophoresis was performed in 1% agarose gel
prepared in TBE solution and containing 1 Ag/ml of EtBr as described in
Materials and methods.
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formulations also exhibited a similar behaviour. As ex-
pected, for DOTAP:DOPE/DNA and DOTAP:DOPE:Chol/
DNA complexes, both prepared at a 2/1 (+/ ) charge ratio,
no decrease of their transfection activity was observed
following 20 days of storage at  80 jC. Surprisingly,
however, the high ability of FuGENE 6/DNA to mediate
transfection was rapidly reduced to approximately 30%
(after 1 day of storage), being maintained at this level
during 20 days (data not shown).
4. Discussion
The variations in size, structure and surface charge
observed for complexes prepared at different lipid/DNA
ratios and even for those prepared at the same ratio are
experimental evidences of the heterogeneous and dynamic
nature of the complexes [25–27]. This heterogeneity can be
attributed to variation of several parameters involved in the
preparation of the complexes, namely the order and rate of
the addition of the components, the maturation time of the
lipoplexes and the type and composition of the cationic
lipid-based gene delivery systems. The control of such
parameters is, therefore, of highest importance in the final
physicochemical properties of the complexes [1,28]. In this
work, we investigated how these properties affect different
cationic lipid-based gene delivery systems, consisting of
both liposomes and nonliposomal structures, in terms of
their biological activity, resistance to the presence of serum,
protective effect against nuclease degradation and stability
under different storage conditions.
The negative zeta potential determined for the complexes
prepared at the 1/2 (+/ ) charge ratio indicates that a
significant amount of DNA is noncondensed and exposed,
thus contributing to the negative surface charge exhibited by
the complexes. In contrast, complexes prepared at the 2/1
(+/ ) charge ratio contain an excess of cationic lipid
capable of fully condensing DNA, thus neutralizing the
negative charges of its phosphate groups [29].
The low values obtained for the mean diameters of the
complexes exhibiting positive or negative surface charge are
most likely due to electrostatic repulsive forces established
between them, thus preventing their aggregation. On the
other hand, for slightly positive complexes (prepared at a
2/1 (+/ ) charge ratio), these repulsive forces are minimal,
thus favouring the formation of large aggregates. It has been
reported that during the maturation process (15 min), Van
der Waals interactions can occur and overcome the existing
repulsive forces, thereby facilitating complex aggregation
[29–32].
As illustrated in Table 1, complexes prepared at a 2/1
(+/ ) charge ratio are those exhibiting the largest sizes,
which favours their sedimentation over the cells, thus
promoting cell internalisation. Besides the enhanced inter-
action of large complexes with cells, it should be considered
that these complexes carry a large number of DNA copies,
which can also explain the high levels of transfection
observed [6,8,33,34].
In addition to the size, the surface charge of the com-
plexes also plays an important role in determining lipoplex–
cell interaction. The comparison of the results presented in
Table 1 and Fig. 2 shows that complexes prepared at
different lipid/DNA charge ratios (1/1 and 4/1), although
exhibiting similar sizes, mediate different transfection activ-
ities, which can be due to the extensive interaction of the
positively charged complexes (4/1) with the negatively
charged cell membrane [24,35]. Another important aspect
that should be considered is the degree of DNA condensa-
tion, which increases with increasing the cationic lipid/DNA
charge ratio [36,37]. In fact, an extensive condensation of
DNA may render difficult the dissociation of the complex,
thus preventing intracellular delivery of DNA. This may
explain the lower levels of luciferase gene expression
mediated by the 8/1 (+/ ) complexes as compared to 4/1
(+/ ) complexes.
The results obtained using different liposome formula-
tions (DOTAP:Chol (1/1); DOTAP:DOPE (1/1); DOTAP:
DOPE:Chol (2/1/1)) are in agreement with previous reports
showing that the composition of the cationic liposomes is
also relevant for the biological activity of the resulting
complexes [38,39]. This aspect is reinforced by comparing
the transfection activity mediated by the referred formula-
tions to that observed for those obtained from commercially
available transfection reagents (DOTAP; DOSPER and
FuGENE 6). DOSPER is a multivalent cationic lipid bearing
four positive charges and thus the 8/1 charge ratio of the
resulting complexes corresponds, in terms of the amount of
cationic lipid, to the 2/1 charge ratio of the complexes
containing DOTAP. Complexes prepared from DOSPER at
Fig. 9. Effect of storage conditions (time and temperature) on the biological
activity of DOTAP:Chol/DNA complexes. Complexes, prepared at the
(+/ ) (2/1) charge ratio were stored at different temperatures and for
different times immediately after their preparation. Transfection activity is
expressed in terms of percentage of control (levels of transfection mediated
by complexes prepared immediately before use). Lipoplexes stored at
 80 jC were previously frozen in liquid nitrogen. The results correspond
to the meanF S.D. obtained from triplicates, and are representative of at
least two independent experiments.
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the 8/1 charge ratio exhibit a transfection activity approx-
imately five times higher than that obtained for the best
condition using liposomes prepared in our laboratory
(DOTAP:Chol/DNA at a 2/1 (+/ ) charge ratio). Never-
theless, this high level of transfection is accompanied by a
significant cell toxicity, in contrast to the absence of
cytotoxicity observed for all the other formulation tested.
In the case of FuGENE 6/DNA complexes, the high trans-
fection activity may be attributed to the chemical nature of
this transfection reagent, which while not being disclosed,
may allow the complexes to overcome more efficiently the
different biological barriers faced by the complexes.
Serum was shown to inhibit transfection activity depend-
ing on the charge and composition of the complexes. The
significant inhibition of the biological activity mediated by
lipoplexes prepared at the 4/1 (+/ ) charge ratio in the
presence of serum is attributed to their extensive interaction
with the negatively charged proteins. These interactions
result either in the dissociation of the complexes and/or in
the formation of large aggregates, which, above a certain
size limit, may be prevented from being internalized by the
cells [39,40]. These same reasons may justify the low
inhibition of transfection in the presence of serum observed
for the approximately neutral complexes (2/1 (+/ ) com-
plexes). Regarding the composition of the formulations, our
results show that the biological activity of complexes
containing cholesterol is less inhibited by the presence of
serum than for those containing DOPE. This observation is
consistent with recent reports that formulations containing
cholesterol are more active in vivo than those containing
DOPE, which has been attributed to their higher stability in
biological fluids [38,41,42]. This higher stability in the
presence of serum is most likely due to the ability of
cholesterol to confer membrane stability in contrast to
DOPE, which is known to have an inverted cone shape that
is associated with membrane fluidity, thus facilitating bind-
ing and/or incorporation of serum proteins [39,40,43]. In
this regard, it is reasonable to assume that the significant
decrease in transfection activity mediated by complexes
prepared from FuGENE 6 in the presence of serum results
from interactions established between them and serum
proteins.
In support of these observations, the results obtained on
the interaction of the complexes with serum proteins show
that highly positively charged complexes interact more
extensively with albumin and C3 complement protein than
complexes whose charge is close to neutrality, stressing that
electrostatic forces play a major role in this process [15,16].
Among highly positively charged complexes, DOPE con-
taining complexes were shown to be more prone to bind to
serum proteins than cholesterol containing complexes, sug-
gesting that lipid composition also plays a role in this
interaction process. For the 4/1 (+/ ) complexes, repulsive
electrostatic interactions result in smaller complexes con-
taining highly curved lipid bilayers. This high curvature
leads to highly unstable lipid bilayers, thus favouring
protein incorporation, which becomes more evident for
complexes containing DOPE, as would be expected, taking
into account the cone shape of this lipid. Nevertheless, our
findings provided evidence that for slightly positive (2/1)
complexes, no significant differences were observed for the
extent of C3 binding, independently of the cationic lip-
osome composition. In contrast, a significant difference in
the extent of albumin binding was observed between
DOTAP:DOPE/DNA and DOTAP:Chol/DNA complexes.
A possible explanation for this differential behaviour is that
differences in the molecular weight and structure of the
proteins (C3 exhibits a higher molecular weight than albu-
min) may cause differences in the extent of their interaction
with the complexes, especially when the charge of the
complexes is attenuated. For albumin, being a smaller
protein, besides charge, the lipid composition will determine
the extent of interaction, namely through its association with
the lipid bilayer, this being favoured by DOPE containing
membranes. Surprisingly, however, results on transfection
activity indicate that the effect of lipid composition, in the
presence of serum, was more pronounced for the 2/1 than
for 4/1 (+/ ) charge ratio complexes. A possible explan-
ation is that for the 4/1 (+/ ) complexes the degree of
binding to serum proteins is enough to inhibit transfection
activity in such an extent, thus masking the effect of lipid
composition. Overall, these results suggest that DOTAP:-
Chol/DNA complexes constitute good candidates for in vivo
gene delivery, since their low ability to interact with serum
proteins predicts that they will be stable in circulation for
long periods, thus allowing them to reach target organs,
while remaining active [42,44].
The studies on the access of EtBr to DNA indicate that
for the 1/2 (F ) charge ratio complexes, a significant
amount of DNA (70%) is exposed, which is in agreement
with the highly negative value obtained for their zeta
potential. Electron microscopy studies performed with cat-
ionic liposome/DNA complexes, for which 65% of DNA
was available to EtBr intercalation, indicate that these
complexes exhibit a structure where DNA can be detected,
suggesting that part of it is free and noncondensed [45]. On
the other hand, the absence of EtBr intercalation for
DOTAP:Chol/DNA complexes prepared at the 2/1 and 4/1
lipid/DNA charge ratios shows that DNA is condensed and
fully protected, in contrast to what was observed for
DOTAP:DOPE/DNA complexes (at the same charge ratios).
Regarding complexes composed of FuGENE 6, our results
show that DNA is not completely condensed. Nevertheless,
this lack of condensation cannot be associated with the
presence of free DNA, since their zeta potential is positive,
suggesting that DNA is covered by FuGENE 6 [45].
Regarding the protection of DNA complexed with the
liposomes, the results on the access of EtBr to DNA should
be taken with caution since, being a small molecule, it can
reach DNA domains that may not be available to DNase I
digestion [46]. In an attempt to clarify this issue, DNase I
degradation assays were performed for some of the formu-
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lations tested. The results obtained indicate that positively
charged cationic liposome/DNA complexes ensure a higher
degree of DNA protection, this being essentially complete
for complexes prepared at 2/1 and 4/1 charge ratios,
independent of the lipid composition of the complexes.
These results reinforce the importance of performing the
DNase I degradation assay, which is more biologically
relevant than the EtBr access assay. Nevertheless, for com-
plexes prepared from FuGENE 6 at a 3/1 (v/w) ratio, a
significant amount of genetic material was degraded by
DNase I, thus confirming the results obtained from studies
using EtBr.
Regarding the effect of time and temperature of storage
of the complexes on their biological activity, the significant
inhibition observed when the cationic liposome/DNA com-
plexes are stored at 25 and 4 jC can be attributed to the
formation of large aggregates, which as referred above, may
prevent their cell internalisation and consequent intracellular
gene delivery [47,48]. The loss of approximately 50% of the
transfection activity of the complexes stored for 24 h at
 20 jC is most likely due to structural changes of the
complexes during the freezing process, since 50% of their
biological activity remains unaltered for longer periods of
storage [19,20]. In fact, when the complexes are rapidly
frozen and stored at  80 jC, their ability to mediate
transfection is essentially preserved for at least 20 days.
This hypothesis was supported by the observation that no
major modifications of size and charge of the complexes
occurred under these conditions. In contrast to what was
observed for the case of cationic liposome/DNA complexes,
this process of freezing and storage at  80 jC is not
suitable to maintain the transfection activity of FuGENE
6/DNA complexes.
Taking into account the parameters affecting the forma-
tion and structure of lipoplexes, their biological stability,
and those affecting their mode of interaction with cells, it
can be concluded that the design of a nonviral vector
capable of fulfilling the conflicting requirements imposed
by each of the different stages involved in the gene delivery
process is a challenging task. The results obtained in this
work show that the complexes leading to the highest bio-
logical activity are those exhibiting high sensitivity to the
presence of serum and lower protection against DNase I. On
the other hand, lipoplexes that are able to protect DNA
against enzymatic degradation and are resistant to the
presence of serum are not so efficient in mediating gene
delivery. Nevertheless, the ability to protect DNA and to
exhibit serum resistance are major requirements for in vivo
applications as long as the physicochemical properties of the
complexes, namely size and charge, will be suitable for such
purpose. Our findings reinforce the importance of fully
characterizing cationic liposome/DNA complexes and of
comparing different lipid-based gene delivery systems, in
order to allow the identification of critical formulations
parameters aiming at obtaining a suitable vector for appli-
cation in gene therapy.
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